Dr. Reddy’s Laboratories Ltd ADR

Stock Chart, Company Information, and Scan Results

$14.43(as of Jul 22, 3:57 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Dr. Reddy’s Laboratories Ltd ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$14.43
Ticker SymbolRDY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees27,811
CountyUSA
Market Cap$12,166.6M
EBIDTA88,840.0M
10-Day Moving Average14.58
P/E Ratio0.21
20-Day Moving Average14.85
Forward P/E Ratio17.92
50-Day Moving Average14.87
Earnings per Share0.79
200-Day Moving Average14.40
Profit Margin18.74%
RSI38.25
Shares Outstanding832.1M
ATR0.23
52-Week High16.89
Volume1,579,518
52-Week Low12.26
Most Recent Support Level14.46
Book Value337,166.0M
Most Recent Resistance Level14.77
P/B Ratio0.04
Upper Keltner15.36
P/S Ratio0.04
Lower Keltner14.34
Debt-to-Equity Ratio15.36
Next Earnings Date10/24/2025
Cash Surplus-115,738.0M
Next Ex-Dividend Date07/25/2025

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Dr. Reddy’s Laboratories Ltd ADR In Our Stock Scanner

example chart graphic
Date: Jul 22, 2025Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Blue Chip Stocks with Low PE RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.